Channel Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:CHRO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Sep 24	BuyUS$5,044	Francis Knuettel	Individual	5,200	US$0.97
12 Sep 24	BuyUS$9,825	Richard Malamut	Individual	10,400	US$0.94
11 Sep 24	BuyUS$10,955	Francis Knuettel	Individual	12,000	US$0.94
21 Feb 24	BuyUS$100,002	Ezra Friedberg	Individual	16,667	US$6.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CHRO?
Owner Type	Number of Shares	Ownership Percentage
Institutions	128,738	2.14%
Individual Insiders	1,225,825	20.3%
General Public	1,458,346	24.2%
Private Companies	3,215,102	53.3%

Dilution of Shares: CHRO only recently listed within the past 12 months

Top Shareholders

Top 20 shareholders own 75.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.6%	Ezra Friedberg	1,058,105	US$996.1k	1.6%	no data
12.4%	Chromocell Corporation	747,187	US$703.4k	0%	no data
8.02%	Motif Pharmaceuticals Limited	483,406	US$455.1k	0%	no data
7.82%	Boswell Prayer Ltd	471,592	US$444.0k	0%	no data
7.37%	Aperture Healthcare Ventures Ltd.	444,071	US$418.0k	0.23%	no data
6.37%	Benuvia Operations, LLC	384,226	US$361.7k	0%	no data
6.12%	AME Equities LLC	369,178	US$347.5k	0%	no data
4.54%	MDB Merchants Park LLC	273,776	US$257.7k	0%	no data
2.13%	Francis Knuettel	128,153	US$120.6k	-75.1%	no data
0.78%	Avantax Planning Partners, Inc.	47,205	US$44.4k	0%	no data
0.69%	Waxcap Inc.	41,666	US$39.2k	0%	no data
0.59%	3i Fund	35,625	US$33.5k	-88.8%	0.48%
0.48%	Todd Davis	29,167	US$27.5k	0%	no data
0.43%	Two Sigma Securities, LLC, Asset Management Arm	26,061	US$24.5k	0%	no data
0.17%	Wealth Enhancement Advisory Services, LLC	10,400	US$9.8k	0%	no data
0.17%	Richard Malamut	10,400	US$9.8k	0%	no data
0.083%	Geode Capital Management, LLC	5,010	US$4.7k	0%	no data
0.069%	Dominion Capital LLC	4,167	US$3.9k	0%	2.33%
0.0043%	Tower Research Capital Europe Limited	259	US$244.0	4,220%	no data
0.00018%	Bank of America Corporation, Asset Management Arm	11	US$10.2	22.2%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/15 23:39
End of Day Share Price	2025/01/15 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Channel Therapeutics Corporation is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Molloy	Alliance Global Partners